Interest in clinical trials is high, but barriers like cost and lack of doctor communication hinder participation. Survey shows patient eagerness.

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

In 2025, Australian women are still suffering in silence. It's a confronting reality: 82 per cent of women feel they are the ...

Reports Q4 revenue $2.6M, consensus $3.35M.”With commercial preparations underway, we believe we are well positioned to launch TNX-102 SL for ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says.About 40% of ...

A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models.

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...

Top Lifestyle, Beauty and Mommy Blog on Skincare, Makeup, Health, Fitness, Parenting, Fashion, Tech, Food, and Travel in the ...

Addressing the GBV problem in Nigeria calls for increased efforts across the board. There is, therefore, an urgent need for ...

About 40% of adults with chronic pain have anxiety or depression, according to new overseas research covering data from 50 ...